Effects of subchronic administration of metrifonate on cholinergic neurotransmission in rats

Neurochemical Research

Volumn 23, Issue 7, 1998, Pages 931-938

  Hinz, V C ^a   Kolb, J ^b   Schmidt, B H ^a  

^a MEDA Manufacturing GmbH   (Germany)

^b BAYER AG   (Germany)

Author keywords

Alzheimer's disease; Blood; Brain; Cholinergic system; Cholinesterase inhibition; Metrifonate; Rat; Subchronic administration

Indexed keywords

CHOLINESTERASE; CHOLINESTERASE INHIBITOR; METRIFONATE; QUINUCLIDINYL BENZILATE;

ACETYLCHOLINE RELEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CHOLINERGIC ACTIVITY; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG SAFETY; MALE; NEUROTRANSMISSION; NONHUMAN; ORAL DRUG ADMINISTRATION; PREDICTION; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; STEADY STATE;

ANIMALS; BRAIN; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; MALE; RATS; RATS, WISTAR; RECEPTORS, CHOLINERGIC; SYNAPTIC TRANSMISSION; TRICHLORFON;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0031824505     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021072119502     Document Type: Article

References (51)

1. Perry, E. K., Tomlinson, E., Blessed, G., Bergmann, K., Gibson, P. H., and Perry, R. H. 1978. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. J. Med. 42:1457-1459.
2. Bierer, L. M., Haroutunian, V., Gabriel, S., Knott, P. J., Carlin, L. S., Purohit, D. P., Perl, D. P., Schmeidler, J., Kanof, P., and Davis, K. L. 1995. Neurochemical correlates of dementia severity in Alzheimer's disease: Relative importance of the cholinergic deficits. J. Neurochem. 64:749-760.
3. Reisine, T., Yamamura, H. I., Bird, E. D., Spokes, E., and Enna, S. J. 1978. Pre- and postsynaptic neurochemical alterations in Alzheimer's disease. Brain Res. 159:477-481.
4. Zubenko, G. S., Moossey, J., Martinez, A. J., Rao, G. R., Kopp, U., and Hanin, I. 1989. A brain regional analysis of morphologic and cholinergic abnormalities in Alzheimer's disease. Arch. Neurol. 46:634-638.
5. Mash, D. C., Flynn, D. D., and Potter, L. T. 1985. Loss of M2 muscarinic receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science 228:1115-1117.
6. Whitehouse, P. J., Martino, A. M., Wagster, M. V., Price, D. L., Mayeux, R., Atack, J. R., and Kellar, K. J. 1988. Reductions in 3H-nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease - an autoradiographic study. Neurology 38: 720-723.
7. Giacobini, E., DeSarno, P., Clark, B., and McIlhany, M. 1989. The cholinergic receptor system of the human brain. Neurochemical and pharmacological aspects in aging and Alzheimer's disease. In A. Nordberg (Ed.), Progress in Brain Research, Vol. 79, Elsevier, Amsterdam, pp. 335-343.
8. Bowen, D. M., Benton, J. S., Spillane, J. A., Smith, C. C. T., and Allen, S. J. 1983. Choline acetyltransferase activity and histopathology of frontal cortex from biopsies of demented patients. J. Neurol. Sci. 57:181-212.
9. Giacobini, E. 1987. Modulation of brain acetylcholine levels with cholinesterase inhibitors as a treatment of Alzheimer's disease. Keio J. Med. 36:381-391.
10. Becker, R. E., and Giacobini, E. 1988. Mechanisms of cholinesterase inhibition in senile dementia of the Alzheimer type: clinical, pharmacological, and therapeutic aspects. Drug Dev. Res. 12:163-195.
11. Jaen, J. C., and Davis, R. E. 1993. Cholinergic therapies for Alzheimer's disease: acetylcholinesterase inhibitors of current clinical interest. Curr. Opin. Invest. Drugs 2:363-377.
12. Weinstock, M. 1995. The pharmacotherapy of Alzheimer's disease based on the cholinergic hypothesis: an update. Neurodegeneration 4:349-356.
13. Giacobini, E. 1991. The second generation of cholinesterase inhibitors: pharmacological aspects. In: Cholinergic Basis for Alzheimer Therapy (R. Becker and E. Giacobini, eds.) Birkhäuser, Boston, pp 247-262.
14. Becker, R. E., Colliver, J., Elble, R., Feldman, E., Giacobini, E., Kumar, V., Markwell, S., Moriearty, P., Parks, R., Shillcutt, S. D., Unni, L., Vicari, S., Womack, C., and Zee, R. F. 1990. Effects of metrifonate, a long-acting cholinesterase inhibitor, in Alzheimer disease: Report of an open trial. Drug Dev. Res. 19:425-434.
15. Bieber, F., Creed Pettigrew, L., Mas, J., Schmitt, F., and Wermeling, D. 1995. Results of a phase lia clinical study trial with metrifonate. Psychopharmacol. Bull. 31:554.
16. Cummings, J., Bieber, F., Mas, J., Orazem, J., and Gulanski, B. 1996. Metrifonate in Alzheimer's Disease - results of a dose-finding study. Neurobiol. Aging 17 (Suppl.):S153-S154.
17. Nordgren, I., Bergström, M., Holmstedt, B., and Sandoz, M. 1978. Transformation and action of metrifonate. Arch. Toxicol. 41:31-41.
18. Hallak, M., and Giacobini, E. 1987. A comparison of the effects of two inhibitors on brain cholinesterase. Neuropharmacology 26: 521-530.
19. Hallak, M., and Giacobini, E. 1989. Physostigmine, tacrine and metrifonate: the effect of multiple doses on acetylcholine metabolism in rat brain. Neuropharmacology 28:199-206.
20. Hinz, V. C., Grewig, S., and Schmidt, B. H. 1996. Metrifonate and dichlorvos: Effects of a single oral administration on cholinesterase activity in rat brain and blood. Neurochem. Res. 21:339-345.
21. DuBois, K. P., and Cotter, G. J. 1955. Studies on the toxicity and mechanism of action of dipterex. Arch. Industr. Health 11:53-60.
22. Reiner, E., and Peština, R. 1979. Regeneration of cholinesterase activities in humans and rats after inhibition of 0,0-dimethyl 2,2-dichlorovinyl phosphate. Toxicol. Appl. Pharmacol. 49:451-454.
23. Ellman, G. L., Courtney, K. D., Andres, V. Jr., and Featherstone, R. M. 1961. A new, rapid colorimetric determination of acetyl-cholinesterase activity. Biochem. Pharmacol. 7:88-95.
24. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275.
25. Dixon, W. J. 1959. Analyses of extreme values. Annals of Mathematical Statistics 21:488-506.
26. Dixon, W. J. 1959. Ratios involving extreme values. Annals of Mathematical Statistics 22:68-78.
27. Holmstedt, B., Nordgren, I., Sandoz, M., and Sundwall, A. 1978. Metrifonate. Summary of toxicological and pharmacological information available. Arch. Toxicol. 41:3-29.
28. Jewsbury, J. M. 1981. Metrifonate in schistosomiasis-therapy and prophylaxis. Acta Pharmacol. Toxicol. 49:123-130.
29. Davis, A. 1993. Antischistosomial drugs and clinical practice. Human Schistosomiasis, 367-404.
30. Hinz, V. C., Grewig, S., and Schmidt, B. H. 1996. Metrifonate induces cholinesterase inhibition exclusively via slow release of dichlorvos. Neurochem. Res. 21:331-337.
31. Mori, F., Cuadra, G., and Giacobini, E. 1995. Metrifonate effects on acetylcholine and biogenic amines in rat cortex. Neurochem. Res. 20:1081-1088.
32. Björklund, M., Jäkälä, P., Schmidt, B., Riekkinen, M., Koivisto, E., and Riekkinen, P. Jr. 1996. An indirect cholinesterase inhibitor, metrifonate, increases neocortical EEG arousal in rats. NeuroReport 7:1097-1101.
33. Bassant, M. H., Jazat-Poindessous, F., and Lamour, Y. 1996. Effects of metrifonate, a cholinesterase inhibitor, on local cerebral glucose utilization in young and aged rats. J. Cerebral Blood Flow Metab. 16:1014-1025.
34. Blokland, A., Hinz, V., and Schmidt, B. H. 1995. Effects of metrifonate and tacrine in the spatial Morris task and modified Irwin test: evaluation of the efficacy/safety profile in rats. Drug Dev. Res. 36:166-179.
35. van der Staay, F. J., Hinz, V. C., and Schmidt, B. H. 1996. Effects of metrifonate on escape and avoidance learning in young and aged rats. Behavioural Pharmacol. 7:56-64.
36. van der Staay, F. J., Hinz, V. C., and Schmidt, B. H. 1996. Effects of metrifonate, its transformation product dichlorvos, and other organophosphorus and reference cholinesterase inhibitors on Morris water-escape behavior in young-adult rats. J. Pharmacol. Exp. Ther. 278:697-708.
37. Riekkinen, P. Jr., Schmidt, B. H., Stefanski, R., Kuitunen, J., and Riekkinen, M. 1996. Metrifonate improves spatial navigation and avoidance behavior in scopolamine-treated, medial septal-lesioned and aged rats. Eur. J. Pharmacol. 309:121-130.
38. Kronforst-Collins, M. A., Moriearty, P. L., Ralphs, M., Becker, R. E., Schmidt, B. H., Thompson, L. T., and Disterhoft, J. F. 1997. Metrifonate treatment enhances acquisition of eye-blink conditioning in aging rabbits. Pharmacol. Biochem. Behav. 56:103-110.
39. Hinz, V. C., Blokland, A., van der Staay, F. J., Gebert, I., Schuurman, T., and Schmidt, B. H. 1996. Receptor interaction profile and CNS general pharmacology of metrifonate and its transformation product dichlorvos in rodents. Drug Dev. Res. 38:31-42.
40. Pope, C. N., Chakrabort, T. K., Chapman, M. L., and Farrar, J. D. 1992. Long-term neurochemical and behavioral effects induced by acute chlorpyrifos treatment. Pharmacol. Biochem. Behavior 42:251-256.
41. Bushnell, P. J., Padilla, S. S., Ward, T., Pope, C. N., and Olszyk, V. B. 1991. Behavioral and neurochemical changes in rats dosed repeatedly with diisopropylfluorophosphate. J. Pharmacol. Exp. Ther. 256:741-750.
42. McDonald, B. E., Costa, L. G., and Murphy, S. D. 1988. Spatial memory impairments and central muscarinic receptor loss following prolonged treatment with organophosphate. Toxicol. Letters 40:47-56.
43. Katz, L. S., and Marquis, J. K. 1989. Modulation of central muscarinic receptor binding in vitro by ultralow levels of the organophosphate paraoxon. Toxicol. Appl. Pharmacol. 101:114-123.
44. Clement, J. G. 1991. Effect of a single dose of acetylcholinesterase inhibitor on oxotremorine- and nicotine-induced hypothermia in mice. Pharmacol. Biochem. Behav. 39:929-934.
45. Silveira, C. L., Eldefrawi, A. T., and Eldefrawi, M. E. 1990. Putative M2 muscarinic receptors of rat heart have high affinity for organophosphorus anticholinesterases. Toxicol. Appl. Pharmacol. 103:474-481.
46. Sterri, S. H. 1981. Factors modifying the toxicity of organophosphorous compounds including dichlorvos. Acta Pharmacol. Toxicol. 49:67-71.
47. Wenthold, R. J., Mahler, H. R., and Moore, W. J. 1974. The half life of acetylcholinesterase in mature rat brain. J. Neurochem. 22: 941-943.
48. Yaksh, T. L., Filbert, M. G., Harris, L. W., and Yamamura, H. I. 1975. Acetylcholinesterase turnover in brain, cerebrospinal fluid and plasma. J. Neurochem. 25:853-860.
49. Nordgren, I., Lundgren, G., Puu, G., and Holmstedt, B. 1984. Stereoselectivity of enzymes involved in toxicity and detoxification of soman. Arch. Toxicol. 55:70-75.
50. Arthur, B. W., and Cassida, J. E. 1957. Mode of action of insecticides. Metabolism and selectivity of 0,0-dimethyl 2,2,2-trichloro-1-hydroxyethyl phosphonate and its acetyl and vinyl derivatives. J. Agric. Food Chem. 5:186-192.
51. Blair, D., Hoadley, E. C., and Hutson, D. H. 1975. The distribu tion of dichlorvos in the tissues of mammals after its inhalation or intravenous administration. Toxicol. Appl. Pharmacol. 31:243-253.